Showing results (71-80 of 790) with videos related to
Sort By:
Pageof 79
Autophagy|June 7, 2014
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapyPhilip L Lorenzi, Sofie Claerhout, Gordon B Mills, et al.Molecular & Cellular Proteomics : MCP|May 3, 2018
Credentialing Individual Samples for Proteogenomic AnalysisWei Zhao, Jun Li, Rehan Akbani, et al.Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.Current Drug Targets|September 15, 2012
Proteomic classification of breast cancerDalia Kamel, Bernadette Brady, Adel Tabchy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Future of personalized medicine in oncology: a systems biology approachAna Maria Gonzalez-Angulo, Bryan T J Hennessy, Gordon B MillsMolecular Oncology|December 17, 2008
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cellsYutaka Hasegawa, Mandi Murph, Shuangxing Yu, et al.Trends in Molecular Medicine|June 3, 2026
Engaging the ZBP1 axis: from nucleic acid stress to antitumor immunityZhiqi Liao, Linghui Wang, Gordon B Mills, et al.Drugs of the Future|November 25, 2014
MODULATION OF AUTOPHAGY AND ITS POTENTIAL FOR CANCER THERAPYSofie Claerhout, Philip L Lorenzi, John N Weinstein, et al.Nature Reviews. Cancer|March 10, 2022
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancerMarilyne Labrie, Joan S Brugge, Gordon B Mills, et al.JCO Clinical Cancer Informatics|April 25, 2020
Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein ArraysMei-Ju May Chen, Jun Li, Gordon B Mills, et al.Pageof 79